COVID-19 Impact on Digital Therapeutic in Healthcare and Pharmaceutical Industry
Coronavirus pandemic has generated an unpredictable effect on human daily lives as well as on the global economy. The coronavirus has a knockout effect on healthcare industries too and created a notable effect or burden on the already pinched healthcare systems across the world. As the pandemic increases, day by day the healthcare professional overworked their duties to overcome the pandemic but a continuously rising number of cases cause major problems. Due to this patients are looking towards digital technologies for disease monitoring as well as for treatment.
COVID-19 outbreak has also made healthcare professionals look for alternative methods to traditional systems and processes. This is leading to an expedited adoption of digital therapeutics across the industry both from providers and consumers. During the pandemic, several healthcare systems have divided healthcare requirements into essential and non-essential based on urgency and the overall requirement for care. As the non-essential requirements are given less priority during the pandemic, patients are moving towards the digital therapeutics solutions. This is augmenting the adoption of digital therapeutics apps across a variety of therapeutic areas such as mental health illness, substance used disorders, opioid used disorders, cardiovascular diseases, metabolic diseases, inflammatory diseases among others.
Digital therapeutics are entered or invented a long time back they recognized and appreciated from few years especially in this pandemic time. During this crisis time, digital therapeutics play a vital need in self-monitoring as well as the management of chronic diseases. During the pandemic lockdown, there has been an even increased need for patients to self-manage their condition and react in real-time, while still having their doctor monitor their case remotely. These digital therapeutics defined as the “evidence-based therapeutic interventions”, which is supported by the high quality of programs and software as the main ingredient or key parameter to help or assist the patients in prevention, managing, and treating various conditions. Once again in this pandemic called digital therapeutics, as well as prescription digital therapeutics, has come to rescue the serious as well as the normal population.
These apps are easy to download on smartphones, laptops, and tablets and can be linked with patient's daily life and assist the users in disease prevention and overall health management. The COVID-19 outbreak has increased the reliability of patients on digital apps to take an active and informed role in their healthcare. The digital therapeutics solutions have helped to reconnect patients and doctors. Hence, it can be concluded that digital health tools are proving to be invaluable for patients with chronic disease and medical professionals.
The easy availability of smartphones and the need for alternative ways to take care of present health is a notable opportunity for digital therapeutics apps providers to expand features and usage. Companies are focusing on connectivity improvements and the interoperability of apps in terms of data storage and data transfer to healthcare providers. This level of data collection is also useful for tracking overall population health. Before the availability of this kind of data, health authorities were dependent on tedious population studies that had several limitations. Digital therapeutics can provide real-time population health information through mass data collection. As a result, healthcare authorities across the world are taking initiatives for digital therapeutics. Below chart shows the major regulatory change in digital therapeutics which creates a new opportunity for pharma as well as healthcare industries.

this pandemic time, various digital therapeutics executives and other related professionals stated that the increasing demand for effective and scalable treatments as healthcare providers find their services lie down thin and patients find themselves cut off from in-person care. At this time everyone afraid of the coronavirus infection and for the good health patients are desperate and deliberately want some solutions.
According to the Akili Interactive “CEO (Eddie Martucci)” “he said providers should see that these walls are broken down, and they want to respond. Moreover, everyone understands that we have this taste of efficiency and rapid ability to serve the patient, and we're seeing it happen in real-time.
According to David Klein, CEO of “Click Therapeutics” digital therapeutics can deliver an effective treatment through a digital screen. He also said various healthcare industries fighting against this kind of good battle and proved that healthcare professionals can provide effective and better treatment through the digital screen without a waste of time. Moreover, he also said the coronavirus pandemic situation created a positive impact or effects on digital therapeutics and gain importance in that the emergency health crisis and yielded a near-perfect environment.
Read in detail...